Crewe Advisors’s Stryker SYK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$348K Buy
1,106
+24
+2% +$7.56K 0.03% 167
2026
Q1
$355K Buy
1,082
+37
+4% +$13.3K 0.03% 159
2025
Q4
$367K Buy
1,045
+11
+1% +$4.01K 0.03% 154
2025
Q3
$382K Hold
1,034
0.04% 144
2025
Q2
$409K Sell
1,034
-11
-1% -$4.12K 0.06% 106
2025
Q1
$389K Buy
1,045
+5
+0.5% +$1.9K 0.05% 97
2024
Q4
$374K Sell
1,040
-87
-8% -$32.2K 0.05% 101
2024
Q3
$407K Buy
1,127
+6
+0.5% +$2.07K 0.05% 94
2024
Q2
$381K Sell
1,121
-17
-1% -$5.76K 0.04% 124
2024
Q1
$407K Buy
+1,138
New +$383K 0.05% 115
2023
Q3
Sell
-1,041
Closed -$318K 874
2023
Q2
$318K Sell
1,041
-35
-3% -$10.1K 0.04% 104
2023
Q1
$307K Sell
1,076
-7
-0.6% -$1.86K 0.04% 119
2022
Q4
$265K Sell
1,083
-89
-8% -$20.2K 0.04% 125
2022
Q3
$237K Buy
1,172
+53
+5% +$11.1K 0.04% 123
2022
Q2
$223K Buy
+1,119
New +$263K 0.05% 118
2021
Q3
Sell
-23
Closed -$6K 460
2021
Q2
$6K Hold
23
﹤0.01% 323
2021
Q1
$6K Hold
23
﹤0.01% 357
2020
Q4
$6K Hold
23
﹤0.01% 345
2020
Q3
$5K Buy
+23
New +$4.47K ﹤0.01% 368

Other funds holding SYK

Crewe Advisors's SYK Position: Q2 2026 in Review

Crewe Advisors increased its Stryker (SYK) stake by 2.2% in Q2 2026, buying an estimated $7.56K and bringing the position to 1,106 shares worth $348K. The position accounts for 0.03% of the portfolio, ranked #167.

Crewe Advisors first reported a position in SYK in Q3 2020 and has held it in 19 quarters since. The position peaked at $409K in Q2 2025. 788 funds tracked by Wall St. Rank hold SYK as of Q2 2026.

  • Crewe Advisors held 1,106 shares of Stryker worth $348K as of Q2 2026.
  • Crewe Advisors bought 24 Stryker shares in Q2 2026, an estimated $7.56K.
  • Stryker made up 0.03% of Crewe Advisors's portfolio in Q2 2026, its #167 holding.
  • Crewe Advisors first reported a position in Stryker in Q3 2020 and has held it in 19 quarters since.
  • Crewe Advisors's Stryker position peaked at $409K in Q2 2025.
  • 788 funds tracked by Wall St. Rank held Stryker as of Q2 2026.

Based on Crewe Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.